Release of growth factors at wound healing stages
US12403179B2 · kind B2 · utility
0Cited by
32References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 18, 2022 |
| Grant date | Sep 2, 2025 |
| Priority date | — |
| Expiry date | Apr 25, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2300/25
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides collagen-binding agents that can be used to treat wounds, ischemic heart disease, and other conditions. The collagen-binding agents comprise a therapeutic agent, a protease cleavage site, and a collagen-binding domain. The present invention further provides pharmaceutical compositions and biomedical devices comprising the disclosed collagen-binding agents, as well as methods for treating a condition using the collagen-binding agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.